Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-21-001007
Filing Date
2021-08-13
Accepted
2021-08-13 16:01:25
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PRIVATE HEALTHCARE GP III, LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 118167
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 11330
  Complete submission text file 0000929638-21-001007.txt   131348
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Subject) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92766 | Film No.: 211171978
SIC: 2834 Pharmaceutical Preparations